Document is current

Any future updates will be listed below

Correction to: AVT02: An Adalimumab Biosimilar

Crossref DOI link: https://doi.org/10.1007/s40261-022-01211-0

Published Online: 2022-10-19

Published Print: 2022-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark